November 2009

19 November 2009
Grenoble, France, and Framingham, MA, 17 November, 2009 – CYTOO SA, a provider of innovative enabling technologies and products for high content cell analysis, announces today the opening of its wholly-owned U.S.-based subsidiary, CYTOO Inc., naming William T. Sharp president and CEO. Sharp also becomes a member of the Board of parent company Cytoo SA. Sharp, who brings 30 years’ life science tools, diagnostics, and clinical product market experience to CYTOO, will have worldwide responsibilities for sales and marketing. He will also be charged with setting up co-distribution and...